Plakous Therapeutics: Funding, Investors & Team (Oct 2026)
Plakous Therapeutics, a human biologics company that specializes in restorative and regenerative healing. The company advances in regenerative healing by manufacturing bio-therapeutics from the post-delivery human placenta. It establishes a safe and effective therapeutic platform to promote and sustain healing using the placental cytokines and growth factors that orchestrate fetal development and also allow the body to heal itself. Seth Tomblyn and Scott Washburn co-founded the company in 2016 and Headquartered in Winston Salem, North Carolina.
Plakous Therapeutics has raised $2.0M across 3 funding rounds on record, the most recent a Grant of $60k announced in Jul 2022.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Plakous Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Plakous Therapeutics Funding Rounds
Plakous Therapeutics raised $1.5M in a Grant announced in Aug 2021.
7 months later, a Grant of $400k was announced in Mar 2022.
4 months later, a Grant of $60k was announced in Jul 2022.
Plakous Therapeutics Founders and Leadership Team
Contact details for the Plakous Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Plakous Therapeutics Funding Compared to Other Biotechnology Startups
Plakous Therapeutics' latest round of $60k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Plakous Therapeutics in Biotechnology and Winston Salem
Companies Similar to Plakous Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Plakous Therapeutics Funding FAQs
What does Plakous Therapeutics do?
Plakous Therapeutics, a human biologics company that specializes in restorative and regenerative healing. The company advances in regenerative healing by manufacturing bio-therapeutics from the post-delivery human placenta. It establishes a safe and effective therapeutic platform to promote and sustain healing using the placental cytokines and growth factors that orchestrate fetal development and also allow the body to heal itself. Seth Tomblyn and Scott Washburn co-founded the company in 2016 and Headquartered in Winston Salem, North Carolina.
How much funding has Plakous Therapeutics raised?
Plakous Therapeutics has raised $2.0M across 3 rounds on record. The most recent is a Grant of $60k announced in Jul 2022.
When did Plakous Therapeutics last raise funding?
Plakous Therapeutics' most recent funding round on record is a Grant of $60k, announced in Jul 2022.
Who founded Plakous Therapeutics?
FundedIQ lists Scott Washburn (Founder) at Plakous Therapeutics.
Who is the CEO of Plakous Therapeutics?
Robert Boyce is listed as CEO at Plakous Therapeutics.
Where is Plakous Therapeutics headquartered?
Plakous Therapeutics is based in Winston Salem, North Carolina, United States.
How many employees does Plakous Therapeutics have?
Plakous Therapeutics is in the 1-10 employee band.
How does Plakous Therapeutics' funding compare to other Biotechnology startups?
Plakous Therapeutics' latest round of $60k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Plakous Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Plakous Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.